In Infection control. No patient will have an We did not achieve our infection 2014/15 MRSA bacteraemia control targets this year. we said This has been a Quality our No. Priority for the last four No more than The Trust recorded 2 patients as 3 goal years because it has patients will have an positive for MRSA bacteraemia was: such a high impact on MSSA bacteraemia in from April 2014 March 2015. – patient safety. year The Trust has reported a total of We have not made the No more than 17 eleven cases of MSSA bacteraemia progress we would patients will acquire for 2014/2015 against the wish and are Clostridium difficile trajectory of three cases. continuing to have a infection in year high focus on this area. To date there have been 20 cases We will have of hospitable attributed implemented an Clostridium difficile reported; 7 of antimicrobial reduction those cases have been associated strategy and a with a lapse in care, for example, stewardship team inappropriate antibiotic prescribing. The remaining 13 cases have been scrutinised and assessed as unavoidable. The antimicrobial stewardship programme is now embedded in the with daily antimicrobial audits of compliance undertaken by the Consultant Microbiologist and Antimicrobial Pharmacist. In Venous We will achieve the The has achieved the 95% 2014/15 national target consistently each Thromboembolism 95% national target for we said (VTE) quality standards month since May 2014. our No. relating to VTE. 4 goal VTE (a blood clot) is a A database and dedicated VTE was: major contributor to We will develop a clerk are in place to monitor severe illness or death assessments of patients. database and in the UK. mechanism to work in time” so that we “real We have improved our know which, if any, performance and patients have not been embedded this change assessed. in our clinical practice.
In 2014/15 we said our No. 3 goal was: Infection control. This has been a Quality Priority for the last four years because it has such a high impact on patient safety. We have not made the progress we would wish and are continuing to have a high focus on this area. No patient will have an MRSA bacteraemia No more than patients will have an MSSA bacteraemia in year No more than 17 patients will acquire Clostridium difficile infection in year We will have implemented an antimicrobial reduction strategy and a stewardship team We did not achieve our infection control targets this year. The Trust recorded 2 patients as positive for MRSA bacteraemia from April 2014 – March 2015. The Trust has reported a total of eleven cases of MSSA bacteraemia for 2014/2015 against the trajectory of three cases. To date there have been 20 cases of hospitable attributed Clostridium difficile reported; 7 of those cases have been associated with a lapse in care, for example, inappropriate antibiotic prescribing. The remaining 13 cases have been scrutinised and assessed as unavoidable. The antimicrobial stewardship programme is now embedded in the with daily antimicrobial audits of compliance undertaken by the Consultant Microbiologist and Antimicrobial Pharmacist. In 2014/15 we said our No. 4 goal was: Venous Thromboembolism (VTE) VTE (a blood clot) is a major contributor to severe illness or death in the UK. We have improved our performance and embedded this change in our clinical practice. We will achieve the 95% national target for quality standards relating to VTE. We will develop a database and mechanism to work in “real time” so that we know which, if any, patients have not been assessed. The has achieved the 95% national target consistently each month since May 2014. A database and dedicated VTE clerk are in place to monitor assessments of patients.
Agenda%20Item%201000%2015%20%20Draft%2020142015%20Quality%20Account.docx